What this means
Doctors and nurses will use a digital tool called Fragiclic during routine visits with patients aged 65 and over. The study will track how many patients get frailty screening or assessment over 12 months.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 65 and over
- Where
- 1 site
The science
- Registered title
- Implementation of a Clinical Decision Support System in Primary Care for the Screening and Assessment of Frailty in Patients Aged 65 and Over
- Trial ID
- NCT07570628 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Frailty at Older Adults, Primary Care, Geriatric Assessment, Implementation Research, Interprofessional Collaboration
- Sponsor
- CNGE Conseil
- Ages
- 65 Years to no maximum
- Dates
- First posted May 6, 2026 · updated May 13, 2026
Registry summary
This observational study aims to evaluate the real-life use of a digital tool (Fragiclic) by general practitioners (GPs) and nurses to screen and assess frailty in adults aged 65 and over. Frailty is a syndrome that increases the risk of loss of autonomy, falls, hospitalizations, or death. The tool includes simple screening questionnaires (such as SEGAm) and a comprehensive assessment (CGA - Comprehensive Geriatric Assessment) to better manage patients' health.
The main question it aims to answer is:
- What proportion of patients aged 65 and over will benefit from frailty screening or assessment using Fragiclic over 12 months?
A secondary question is
- Does the use of Fragiclic reduce the risk of unplanned hospitalizations or death in these patients?
For the secondary question, researchers will compare patients who received screening or assessment (with or without a Personalized Care Plan (PCP)) to those who did not, to determine if Fragiclic improves their health outcomes.
Participants will not have additional tasks: Their GP or nurse will use Fragiclic during routine consultations. Some patients may be asked to provide information about their health or quality of life (via their healthcare provider).
All data will be collected anonymously and securely
Sites (1)
- MSPU Torcy, Torcy, Rue Charlie-Chaplin, France